Health Insurance Innovations, Inc. (NASDAQ:HIIQ) CFO Michael D. Hershberger sold 5,000 shares of the firm’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $23.22, for a total value of $116,100.00. Following the completion of the sale, the chief financial officer now directly owns 105,369 shares in the company, valued at approximately $2,446,668.18. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Health Insurance Innovations, Inc. (NASDAQ HIIQ) traded up 0.78% on Friday, hitting $25.70. The stock had a trading volume of 587,871 shares. The company has a market cap of $303.70 million, a P/E ratio of 23.19 and a beta of 0.64. The stock’s 50-day moving average is $22.18 and its 200-day moving average is $18.49. Health Insurance Innovations, Inc. has a 52-week low of $3.80 and a 52-week high of $26.80.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its quarterly earnings data on Wednesday, May 3rd. The financial services provider reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. The firm had revenue of $55.87 million during the quarter, compared to analyst estimates of $54.18 million. Health Insurance Innovations had a net margin of 4.77% and a return on equity of 20.05%. Analysts expect that Health Insurance Innovations, Inc. will post $1.44 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/07/16/michael-d-hershberger-sells-5000-shares-of-health-insurance-innovations-inc-hiiq-stock-updated.html.

A number of research analysts have recently commented on the company. UBS AG upgraded Health Insurance Innovations to an “outperform” rating in a research note on Thursday, May 4th. Zacks Investment Research lowered Health Insurance Innovations from a “buy” rating to a “hold” rating in a research report on Wednesday. Canaccord Genuity reaffirmed a “buy” rating and set a $30.00 target price on shares of Health Insurance Innovations in a research report on Thursday. TheStreet raised Health Insurance Innovations from a “c” rating to a “b-” rating in a research report on Monday, May 22nd. Finally, Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Health Insurance Innovations in a research report on Monday, June 26th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Health Insurance Innovations has an average rating of “Buy” and a consensus price target of $25.83.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Argent Capital Management LLC bought a new position in shares of Health Insurance Innovations during the first quarter worth about $2,094,000. Dynamic Technology Lab Private Ltd bought a new position in shares of Health Insurance Innovations during the first quarter worth about $277,000. SG Americas Securities LLC bought a new position in shares of Health Insurance Innovations during the first quarter worth about $252,000. Millrace Asset Group Inc. bought a new position in shares of Health Insurance Innovations during the first quarter worth about $1,840,000. Finally, Airain ltd acquired a new stake in Health Insurance Innovations during the first quarter valued at approximately $537,000. Institutional investors and hedge funds own 70.48% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Insider Buying and Selling by Quarter for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Stock Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related stocks with our FREE daily email newsletter.